News - Merck Serono

Filter

Current filters:

Merck Serono

Popular Filters

64 to 70 of 70 results

F-Star and Merck Serono in up to 492 million-euro collaboration on novel targeted biologics

09-09-2011

Austrian biotech firm F-Star GmbH has entered into a research, license and commercialization agreement…

BiotechnologyF-StarLicensingMerck KGaAMerck SeronoPharmaceuticalResearch

Merck Serono in deal with Affectis Pharma to develop oral neurodegenerative disease drugs

08-06-2011

Switzerland based Merck Serono, a division of Germany’s Merck KGaA (MRK: DE), has entered into a…

Affectis PharmaceuticalsLicensingMerck KGaAMerck SeronoNeurologicalPharmaceuticalResearch

UK’s NICE recommends naftidrofuryl oxalate for symptoms of peripheral arterial disease

26-05-2011

The National Institute for Health and Clinical Excellence (NICE) has today issued final guidance recommending…

Cardio-vascularEuropeMerck SerononaftidrofurylPharmaceuticalPraxilenePricingRegulation

Merck KGaA US units agree $44.3 million settlement with DoJ; Ranbaxy faces up to $1 billion fine?

05-05-2011

Four US subsidiaries of German drug major Merck KGaA (MRK: DE) - Serono Laboratories, EMD Serono, Merck…

LegalMerck KGaAMerck SeronoNorth AmericaPharmaceuticalRanbaxy LaboratoriesRebif

64 to 70 of 70 results

Back to top